HiRO - Harvest Integrated Research Organization

Leveraging our extensive knowledge, HiRO assists biopharma in developing robust clinical trial strategies amidst the wealth of information on regions, site selection, and patient recruitment capabilities. By harnessing the advantages of diverse regions, we accelerate timelines, save costs, and ensure high-quality data accepted by global authorities. Speak with our experts today to learn how we can support your clinical trial needs. https://lnkd.in/gT4rV36W #ClinicalTrials #Biopharma #GlobalStrategy #HiRO #Expertise #PatientRecruitment

🌟 Join us at BIX Korea and meet our talented team! 🌟 If you're attending the BIOPLUS-INTERPHEX KOREA and have questions about your clinical trial projects that you'd like to discuss, or if you're interested in exploring potential collaborations, we we'd be delighted to meet you for a personalized one-on-one meeting. Our team specializes in offering cross-border clinical trial solutions and is well-equipped to discuss and provide insights on overcoming challenges in this field. Visit our booth at #M14 to connect with us. We're eager to understand your specific needs and explore how we can work together to achieve your goals. #BIXKorea #ClinicalTrialSolutions #CrossBorderCollaboration #IndustryInsights #HiRO

From protocol development to regulatory approvals, we expedite the necessary steps, ensuring a prompt kickstart to your study and a smooth path towards impactful results. With meticulous planning and efficient execution, we provide the support and expertise needed for a successful beginning. Trust us to lay the foundation for your study’s success from the very start. Speak with our experts today to accelerate your next clinical trial. https://lnkd.in/gT4rV36W #ClinicalTrials #RapidStartUp #Biopharma #RegulatoryApprovals #HiRO #ResearchSolutions

Join us at our "Trials Without Borders" 🗺 Webinar Series, as we explore the East Asia region and maximize the value of global studies through Korea and Japan. During this webinar, you will: 🎯 Recognize the strategic importance of Korea and Japan in global drug development. 🎯 Understand the regulatory landscape and important considerations in these countries. 🎯 Gain insights on accelerating clinical trial timelines and utilizing foreign clinical data. 🎯 Learn key factors and successful strategies for obtaining drug approval in a short timeframe. 🎯 Understand the importance of effective communication meetings with drug regulatory authorities. 📅 Date: July 12, 2024 (Friday) ⏰ Time: 16:00-17:00 (GMT+9) 🔗 Registration link: https://lnkd.in/gQCA2bYr Enroll today to connect with our speakers JiHee Noh, Ryosuke Endo, Tsukasa Kiriyama, and discover the limitless possibilities of expanding your global studies through Korea and Japan! #ClinicalTrials #GlobalStudy #EastAsia #WebinarSeries #TrialsWithoutBorders #HiRO

HiRO employed a proactive approach to achieve rapid start-up for a Phase 1 dermatology study. Our dedicated rapid start-up team, with over 20 years of experience, focused on swift ethics and regulatory approvals and concurrent site activation. We achieved full regulatory approval just 40 days from protocol receipt and screened the first patient only 3 days after site activation. Learn more about our rapid start-up strategies here: https://lnkd.in/gzAfAdYN #ClinicalTrials #RapidStartup #HiROANZ #HealthcareInnovation

As a full-service global CRO, HiRO serves as a vital gateway for biotechs aiming to conduct clinical trials across the globe. With our strategic presence in key markets and deep understanding of international regulatory landscapes, we support biotechs to expand their reach and efficiently navigate the complexities of global clinical development. Learn more in our latest blog: https://lnkd.in/gwijjCV3 #GlobalCRO #HiRO #ClinicalTrials #BiotechExpansion #GlobalHealth

The strategic benefits of conducting early-phase studies in Australia and New Zealand are becoming clearer as more biotechs opt to continue into Phase 3 within the region. This transition leverages existing networks and efficiencies developed during earlier trials, providing a seamless progression that can accelerate the path to market. Learn more in our latest blog: https://lnkd.in/gwijjCV3 #ClinicalTrials #Biotech #Phase3 #HiRO #GlobalCRO #ANZRegion

📣 Join HiRO at Bioplus-Interphex (BIX) Korea in Seoul next week! 🌍 Visit our booth #M14 at BIOPLUS-INTERPHEX KOREA, held at COEX from July 10-12. Discover how HiRO excels in cross-border clinical trials, assisting you in expanding into global markets. Are you seeking to conduct clinical trials in APAC, the US, Europe, and beyond? HiRO is your trusted partner. We specialize in providing tailored strategic planning, enabling successful trials across borders. Our local and global teams are adept at navigating the intricacies of global trials, ensuring adherence to local regulations. From the early planning stages to seamless execution, we offer comprehensive end-to-end support. Ya-Han Chang, JiHee Noh, Molly Huang, Becky Lu We are committed to streamlining and accelerating your clinical research endeavors. Don't miss the opportunity to connect with us at booth #M14, where we can discuss how HiRO can support your clinical research aspirations. #HiRO #BIXKorea #CrossBorderTrials #StrategicPlanning #ClinicalResearch

Discover how HiRO is transforming biotech with our innovative, full-service clinical trial solutions. From optimizing early-phase trials to navigating complex global markets, our strategies are designed to accelerate commercialization and enhance research outcomes. Learn more about our unique approach and the advantages we offer to biotechs worldwide in our latest blog. #HiRO #GlobalCRO #ClinicalTrials #Biotech #Innovation #Pharmaceutical

We are excited to announce HiRO’s acquisition of DeltaMed Solutions, an emerging US-based CRO. This acquisition marks a significant milestone in our global expansion strategy, enhancing our capabilities in delivering comprehensive clinical research solutions. With DeltaMed’s expertise in data management, biostatistics, programming, RWE solutions, PK/PD analysis, and more, we’re poised to offer an unparalleled range of services to our clients worldwide. Dr. Karen Chu, Founder and CEO of HiRO, expressed her confidence in the acquisition, "By combining our resources and expertise, we are strongly positioned to become our clients' trusted partner in advancing patient treatments and making a lasting impact on the healthcare landscape. This leverages our collective strengths, ensuring optimal efficiency in conducting clinical trials across a wide range of therapeutic areas in the US, Asia-Pacific, and beyond. This sets us apart as a pioneering force in the highly competitive CRO industry." Dr. Sam Liang, President of DeltaMed Solutions, added, "This opportunity allows us to harness our scientific expertise and well-established presence in the US. Working together, we will offer an enriched, globally integrated suite of services to our clients, driven by our shared dedication to quality, innovation, and patient-centric research. This collaboration will streamline processes and accelerate the development of groundbreaking treatments." Learn more about this strategic move and how it benefits our clients: https://lnkd.in/gNzuqPsx #ClinicalResearch #HealthcareInnovation #CROAcquisition #HiRO #DeltaMedSolutions